In addition to the simple paracrine signals modeled by in vitro systems, ERK activity in cancer cells is likely affected by a mixture of cell–cell, matrix, and nutrient signals from the complex microenvironment, intermixed with the blurring effects of activating pathway mutations [118]. Here, MAPK1 is linked to cancer.